Intellia Therapeutics Inc (NTLA)
21.57
+0.25
(+1.17%)
USD |
NASDAQ |
Apr 19, 16:00
21.45
-0.12
(-0.56%)
After-Hours: 17:04
Intellia Therapeutics Shareholders Equity (Quarterly): 1.050B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.050B |
| September 30, 2023 | 1.037B |
| June 30, 2023 | 1.105B |
| March 31, 2023 | 1.191B |
| December 31, 2022 | 1.236B |
| September 30, 2022 | 824.95M |
| June 30, 2022 | 880.55M |
| March 31, 2022 | 953.75M |
| December 31, 2021 | 1.040B |
| September 30, 2021 | 1.107B |
| June 30, 2021 | 494.81M |
| March 31, 2021 | 545.87M |
| December 31, 2020 | 527.07M |
| September 30, 2020 | 329.62M |
| June 30, 2020 | 351.59M |
| March 31, 2020 | 247.76M |
| December 31, 2019 | 269.88M |
| Date | Value |
|---|---|
| September 30, 2019 | 275.65M |
| June 30, 2019 | 276.87M |
| March 31, 2019 | 264.34M |
| December 31, 2018 | 277.92M |
| September 30, 2018 | 263.27M |
| June 30, 2018 | 279.34M |
| March 31, 2018 | 295.50M |
| December 31, 2017 | 300.60M |
| September 30, 2017 | 175.85M |
| June 30, 2017 | 187.58M |
| March 31, 2017 | 199.88M |
| December 31, 2016 | 209.84M |
| September 30, 2016 | 218.12M |
| June 30, 2016 | 223.60M |
| March 31, 2016 | -27.14M |
| December 31, 2015 | -21.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
247.76M
Minimum
Mar 2020
1.236B
Maximum
Dec 2022
723.40M
Average
824.95M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Moderna Inc | 13.85B |
| Regeneron Pharmaceuticals Inc | 25.97B |
| NeuroMetrix Inc | 20.09M |
| Repligen Corp | 1.971B |
| Pacific Biosciences of California Inc | 701.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.301B |
| Total Liabilities (Quarterly) | 250.81M |
| Current Ratio | 8.666 |